Identification of Small Molecule Activators of BMP Signaling

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Vrijens, Karen ^a   Lin, Wenwei ^b   Cui, Jimmy ^b   Farmer, Dana ^a   Low, Jonathan ^b   Pronier, Elodie ^a,c   Zeng, Fu Yue ^b   Shelat, Anang A ^b   Guy, Kiplin ^b   Taylor, Michael R ^b   Chen, Taosheng ^b   Roussel, Martine F ^a  

^a Departments of Tumor Cell Biology   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4' HYDROXYCHALCONE; APIGENIN; BONE MORPHOGENETIC PROTEIN; DIOSMETIN; FLAVONOID; INHIBITOR OF DIFFERENTIATION 1; INHIBITOR OF DIFFERENTIATION 2; ISOLIQUIRITIGENIN; LUCIFERASE; SMAD PROTEIN; SMAD1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOLECULAR INTERACTION; MYOBLAST; NONHUMAN; OSTEOBLAST; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; UTERINE CERVIX CARCINOMA; ZEBRA FISH;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL LINE, TUMOR; CHALCONE; DRUG DISCOVERY; EMBRYO, NONMAMMALIAN; EMBRYONIC DEVELOPMENT; FLAVONES; GENES, REPORTER; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MICE; MICE, KNOCKOUT; MYOBLASTS; OSTEOBLASTS; SIGNAL TRANSDUCTION; SMALL MOLECULE LIBRARIES; ZEBRAFISH;

EID: 84875092554     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059045     Document Type: Article

References (54)

1. Canalis E, Economides AN, Gazzerro E, (2003) Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24: 218-235.
2. Chen D, Zhao M, Mundy GR, (2004) Bone morphogenetic proteins. Growth Factors 22: 233-241.
3. Reddi AH, Reddi A, (2009) Bone morphogenetic proteins (BMPs): from morphogens to metabologens. Cytokine Growth Factor Rev 20: 341-342.
4. Dale L, Jones CM, (1999) BMP signalling in early Xenopus development. Bioessays 21: 751-760.
5. Watabe T, Miyazono K, (2009) Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res 19: 103-115.
6. Anderson GJ, Frazer DM, McLaren GD, (2009) Iron absorption and metabolism. Curr Opin Gastroenterol 25: 129-135.
7. ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Estevez M, et al. (1994) Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem 269: 16985-16988.
8. Koenig BB, Cook JS, Wolsing DH, Ting J, Tiesman JP, et al. (1994) Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol Cell Biol 14: 5961-5974.
9. Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, et al. (1995) Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci U S A 92: 7632-7636.
10. Moustakas A, Heldin CH, (2002) From mono- to oligo-Smads: the heart of the matter in TGF-beta signal transduction. Genes Dev 16: 1867-1871.
11. Chen Y, Bhushan A, Vale W, (1997) Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase. Proc Natl Acad Sci U S A 94: 12938-12943.
12. Hoodless PA, Haerry T, Abdollah S, Stapleton M, O'Connor MB, et al. (1996) MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85: 489-500.
13. Peng Y, Kang Q, Luo Q, Jiang W, Si W, et al. (2004) Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279: 32941-32949.
14. Ben-Arie N, Bellen HJ, Armstrong DL, McCall AE, Gordadze PR, et al. (1997) Math1 is essential for genesis of cerebellar granule neurons. Nature 390: 169-172.
15. Jeong J, Kang DI, Lee GT, Kim IY, (2010) Bone morphogenetic protein signaling: implications in urology. Korean J Urol 51: 511-517.
16. Pinho RS, Andreoni S, Silva NS, Cappellano AM, Masruha MR, et al. (2011) Pediatric central nervous system tumors: a single-center experience from 1989 to 2009. J Pediatr Hematol Oncol 33: 605-609.
17. Kieran MW, Walker D, Frappaz D, Prados M, (2010) Brain tumors: from childhood through adolescence into adulthood. J Clin Oncol 28: 4783-4789.
18. Ferretti E, De Smaele E, Po A, Di Marcotullio L, Tosi E, et al. (2009) MicroRNA profiling in human medulloblastoma. Int J Cancer 124: 568-577.
19. Thompson MC, Fuller C, Hogg TL, Dalton J, Finkelstein D, et al. (2006) Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 24: 1924-1931.
20. Rios I, Alvarez-Rodriguez R, Marti E, Pons S, (2004) Bmp2 antagonizes sonic hedgehog-mediated proliferation of cerebellar granule neurones through Smad5 signalling. Development 131: 3159-3168.
21. Zhao H, Ayrault O, Zindy F, Kim JH, Roussel MF, (2008) Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development. Genes Dev 22: 722-727.
22. Flora A, Klisch TJ, Schuster G, Zoghbi HY, (2009) Deletion of Atoh1 disrupts Sonic Hedgehog signaling in the developing cerebellum and prevents medulloblastoma. Science 326: 1424-1427.
23. Kimura H, Ng JM, Curran T, (2008) Transient inhibition of the Hedgehog pathway in young mice causes permanent defects in bone structure. Cancer Cell 13: 249-260.
24. Yauch RL, Dijkgraaf GJ, Alicke B, Januario T, Ahn CP, et al. (2009) Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 326: 572-574.
25. Gottfried ON, Dailey AT, (2008) Mesenchymal stem cell and gene therapies for spinal fusion. Neurosurgery 63 pp. 380-391 discussion 391-382.
26. Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, et al. (2008) Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 4: 33-41.
27. Uziel T, Zindy F, Xie S, Lee Y, Forget A, et al. (2005) The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation. Genes Dev 19: 2656-2667.
28. http://www.sigmaaldrich.com/catalog/product/sigma/lo1280?lang=en®ion=US.Accessed 2013 Febrary 13.
29. Nasevicius A, Ekker SC, (2000) Effective targeted gene 'knockdown' in zebrafish. Nat Genet 26: 216-220.
30. Pardridge WM, (2005) The blood-brain barrier: bottleneck in brain drug development. NeuroRx. 2: 3-14.
31. Oetgen ME, Richards BS, (2010) Complications associated with the use of bone morphogenetic protein in pediatric patients. J Pediatr Orthop 30: 192-198.
32. Korchynskyi O, ten Dijke P, (2002) Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 277: 4883-4891.
33. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, et al. (1998) Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev 12: 2424-2433.
34. Zhang JH, Chung TD, Oldenburg KR, (1999) A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 4: 67-73.
35. Mirzoeva S, Kim ND, Chiu K, Franzen CA, Bergan RC, et al. (2008) Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells. Mol Carcinog 47: 686-700.
36. Makita H, Tanaka T, Fujitsuka H, Tatematsu N, Satoh K, et al. (1996) Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin. Cancer Res 56: 4904-4909.
37. Androutsopoulos V, Wilsher N, Arroo RR, Potter GA, (2009) Bioactivation of the phytoestrogen diosmetin by CYP1 cytochromes P450. Cancer Lett 274: 54-60.
38. Tsukamoto S, Aburatani M, Yoshida T, Yamashita Y, El-Beih AA, et al. (2005) CYP3A4 inhibitors isolated from Licorice. Biol Pharm Bull 28: 2000-2002.
39. Nohe A, Hassel S, Ehrlich M, Neubauer F, Sebald W, et al. (2002) The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 277: 5330-5338.
40. Shin GC, Kim C, Lee JM, Cho WS, Lee SG, et al. (2009) Apigenin-induced apoptosis is mediated by reactive oxygen species and activation of ERK1/2 in rheumatoid fibroblast-like synoviocytes. Chem Biol Interact 182: 29-36.
41. Bresnihan B, (1999) Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol 26: 717-719.
42. Yang J, Li X, Al-Lamki RS, Southwood M, Zhao J, et al. (2010) Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo. Circ Res 107: 252-262.
43. Yaffe D, Saxel O, (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725-727.
44. Blau HM, Pavlath GK, Hardeman EC, Chiu CP, Silberstein L, et al. (1985) Plasticity of the differentiated state. Science 230: 758-766.
45. Li G, Peng H, Corsi K, Usas A, Olshanski A, et al. (2005) Differential effect of BMP4 on NIH/3T3 and C2C12 cells: implications for endochondral bone formation. J Bone Miner Res 20: 1611-1623.
46. Buring K, Semb H, (1970) Enzyme patterns during bone induction. Calcif Tissue Res: Suppl:102-104.
47. Vukicevic S, Luyten FP, Reddi AH, (1989) Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proc Natl Acad Sci U S A 86: 8793-8797.
48. Nishimura R, Kato Y, Chen D, Harris SE, Mundy GR, et al. (1998) Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J Biol Chem 273: 1872-1879.
49. Hao J, Ho JN, Lewis JA, Karim KA, Daniels RN, et al. (2010) In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem Biol 5: 245-253.
50. Lele Z, Bakkers J, Hammerschmidt M, (2001) Morpholino phenocopies of the swirl, snailhouse, somitabun, minifin, silberblick, and pipetail mutations. Genesis 30: 190-194.
51. Fisher S, Amacher SL, Halpern ME, (1997) Loss of cerebum function ventralizes the zebrafish embryo. Development 124: 1301-1311.
52. Little SC, Mullins MC, (2004) Twisted gastrulation promotes BMP signaling in zebrafish dorsal-ventral axial patterning. Development 131: 5825-5835.
53. Cooper BJ, Key B, Carter A, Angel NZ, Hart DN, et al. (2006) Suppression and overexpression of adenosylhomocysteine hydrolase-like protein 1 (AHCYL1) influences zebrafish embryo development: a possible role for AHCYL1 in inositol phospholipid signaling. J Biol Chem 281: 22471-22484.
54. Shen Q, Little SC, Xu M, Haupt J, Ast C, et al. (2009) The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. J Clin Invest 119: 3462-3472.